Beyond insulin: Medi-Cal expands patient access to diabetes supplies

June Voros sprang from her couch as a high-pitched beep warned her that she needed a quick dose of sugar.

Global leaders set ambitious targets to end tuberculosis epidemic

World leaders at the United Nations General Assembly’s High-Level Meeting on Tuberculosis have approved a Political Declaration with ambitious new targets for the next five

March 28, 2024

BeiGene’s PD-1 drug approved in EU for first-line oesophageal cancer treatment – Pharmaceutical Technology

Tevimbra is a monoclonal antibody that targets the PD-1 receptor. Credit: rawf8 via Shutterstock. The European Commission has approved BeiGene’s PD-1 inhibitor Tevimbra (tislelizumab) in

November 27, 2024

As pharmaceutical companies bemoan Medicare’s drug negotiations, hospitals and doctors stay mum

The pharmaceutical industry has been up in arms over Medicare’s first list of 10 prescription drugs that will be subject to negotiations. But other major

August 31, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.